The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial

Clinical Nutrition

Volumn 33, Issue 6, 2014, Pages 973-981

  Lee, Sin Ji ^a   Bose, Shambhunath ^b   Seo, Jae Gu ^c   Chung, Won Seok ^c   Lim, Chi Yeon ^b   Kim, Hojun ^a  

^a Dongguk University   (South Korea)

^b Dongguk University   (South Korea)

^c Cellbiotech Co Ltd   (South Korea)

Author keywords

Endotoxin; Gut microbiota; Metabolic disorders; Obesity; Probiotics

Indexed keywords

BOFUTSUSHOSAN; CHOLESTEROL; HERBACEOUS AGENT; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; ENDOTOXIN;

ADULT; AGED; ARTICLE; BACTERIUM COLONY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DOUBLE BLIND PROCEDURE; DYSBIOSIS; ENDOTOXEMIA; ENERGY METABOLISM; EXERCISE; FECES MICROFLORA; FEMALE; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; OBESITY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS THERMOPHILUS; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; BLOOD PRESSURE; FECES; GASTROINTESTINAL TRACT; INTERVENTION STUDY; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYSIOLOGY; PHYTOTHERAPY; QUALITY OF LIFE; SOUTH KOREA; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; DOUBLE-BLIND METHOD; DYSBIOSIS; ENDOTOXEMIA; ENDOTOXINS; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INTERVENTION STUDIES; MICROBIOTA; MIDDLE AGED; OBESITY; PHYTOTHERAPY; PROBIOTICS; QUALITY OF LIFE; REPUBLIC OF KOREA; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT LOSS; YOUNG ADULT;

EID: 84920111425     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.12.006     Document Type: Article

References (30)

1. Angelakis E., Armougom F., Million M., Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012, 7(1):91-109.
2. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3(4):279-288.
3. Harris K., Kassis A., Major G., Chou C.J. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?. JObes 2012, 2012.
4. Manco M., Putignani L., Bottazzo G.F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010, 31(6):817-844.
5. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
6. Maes M., Coucke F., Leunis J.-C. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett 2007, 28(6):739.
7. Caradonna L., Amati L., Lella P., Jirillo E., Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am J Gastroenterol 2000, 95(6):1495-1502.
8. An H.M., Park S.Y., Lee D.K., Kim J.R., Cha M.K., Lee S.W., et al. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 2011, 10:116.
9. Velayudham A., Dolganiuc A., Ellis M., Petrasek J., Kodys K., Mandrekar P., et al. VSL# 3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009, 49(3):989-997.
10. Esposito E., Iacono A., Bianco G., Autore G., Cuzzocrea S., Vajro P., et al. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. JNutr 2009, 139(5):905-911.
11. Shimada T., Kudo T., Akase T., Aburada M. Preventive effects of Bofutsushosan on obesity and various metabolic disorders. Biol Pharm Bull 2008 Jul, 31(7):1362-1367. PubMed PMID: 18591775.
12. Lye H.-S., Kuan C.-Y., Ewe J.-A., Fung W.-Y., Liong M.-T. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009, 10(9):3755-3775.
13. Carr M.C., Brunzell J.D. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. JClin Endocrinol Metab 2004, 89(6):2601-2607.
14. Olefsky J., Reaven G.M., Farquhar J.W. Effects of weight reduction on obesity studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. JClin Invest 1974, 53(1):64.
15. Després J.-P., Ferland M., Moorjani S., Nadeau A., Tremblay A., Lupien P.J., et al. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arterioscler Thromb Vasc Biol 1989, 9(4):485-492.
16. Sartor R.B. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc Natl Acad Sci 2008, 105(43):16413-16414.
17. Cani P.D., Delzenne N.M. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 2009, 9(6):737-743.
18. Kondo S., Xiao J.-Z., Satoh T., Odamaki T., Takahashi S., Sugahara H., et al. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci Biotechnol Biochem 2010, 74(8):1656-1661.
19. Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. JAllergy Clin Immunol 2006, 117(3):696-702.
20. Cani P., Neyrinck A., Fava F., Knauf C., Burcelin R., Tuohy K., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50(11):2374-2383.
21. Purohit V., Bode J.C., Bode C., Brenner D.A., Choudhry M.A., Hamilton F., et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008, 42(5):349-361.
22. Gut microbiota and its possible relationship with obesity. Mayo clinic proceedings 2008, Elsevier. J.K. DiBaise, H. Zhang, M.D. Crowell, R. Krajmalnik-Brown, G.A. Decker, B.E. Rittmann (Eds.).
23. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
24. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37(2):343-350.
25. Ilmonen J., Isolauri E., Poussa T., Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clin Nutr 2011, 30(2):156-164.
26. Park D.-Y., Ahn Y.-T., Huh C.-S., Jeon S.-M., Choi M.-S. The inhibitory effect of Lactobacillus plantarum KY1032 cell extract on the adipogenesis of 3T3-L1 Cells. JMed Food 2011, 14(6):670-675.
27. Armougom F., Raoult D. Use of pyrosequencing and DNA barcodes to monitor variations in Firmicutes and Bacteroidetes communities in the gut microbiota of obese humans. BMC Genomics 2008, 9(1):576.
28. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(7122):1022-1023.
29. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci 2009, 106(7):2365-2370.
30. Duncan S., Lobley G., Holtrop G., Ince J., Johnstone A., Louis P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 2008, 32(11):1720-1724.